Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 16/20 | 0.62 |
| ▸ | WNT1 | P04628 | 15/20 | 0.62 |
| ▸ | GSK3B | P49841 | 13/20 | 0.62 |
| ▸ | CLK2 | P49760 | 5/20 | 0.62 |
| ▸ | CLK3 | P49761 | 5/20 | 0.62 |
| ▸ | TTK | P33981 | 3/20 | 0.49 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19546917 | 0.92 | DYRK1A (0.62) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL19540217 | 0.89 | DYRK1A (0.77) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL23916595 | 0.87 | DYRK1A (0.55) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL19546649 | 0.87 | GSK3B (0.81) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL23916403 | 0.82 | DYRK1A (0.68) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL23048581 | 0.80 | DYRK1A (0.65) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL23916758 | 0.77 | DYRK1A (0.49) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL23741622 | 0.77 | DYRK1A (0.63) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL19517202 | 0.77 | DYRK1A (1.00) | DYRK1AWNT1GSK3BCLK2CLK3 | |
| SCHEMBL22253225 | 0.77 | DYRK1A (0.90) | DYRK1AWNT1GSK3BCLK2CLK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892276-A1 | ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS | BioSplice Therapeutics, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |